Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma

International Journal of Cancer

Volumn 131, Issue 11, 2012, Pages 2537-2546

  Tanaka, Shigetomi ^a   Shiraha, Hidenori ^a   Nakanishi, Yutaka ^a   Nishina, Shin Ichi ^a   Matsubara, Minoru ^a   Horiguchi, Shigeru ^a   Takaoka, Nobuyuki ^a   Iwamuro, Masaya ^a   Kataoka, Junro ^a   Kuwaki, Kenji ^a   Hagihara, Hiroaki ^a   Toshimori, Junichi ^a   Ohnishi, Hideki ^a   Takaki, Akinobu ^a   Nakamura, Shinichiro ^a   Nouso, Kazuhiro ^a   Yagi, Takahito ^a   Yamamoto, Kazuhide ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

cell migration; E cadherin; jagged 1; N cadherin; tumor invasion

Indexed keywords

JAGGED1; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX3; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR TWIST1; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; JAG1 GENE; LIGAND BINDING; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; RUNX3 GENE; SNAI2 GENE; TUMOR SUPPRESSOR GENE; TWIST1 GENE;

CADHERINS; CALCIUM-BINDING PROTEINS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CORE BINDING FACTOR ALPHA 3 SUBUNIT; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MEMBRANE PROTEINS; NUCLEAR PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TWIST TRANSCRIPTION FACTOR; VIMENTIN;

EID: 84867056874     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27575     Document Type: Article

References (50)

1. El-Serag HB, Rudolph KL,. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterol 2007; 132: 2557-76.
2. Garcia M, Jernal A, Ward EM, et al. Global Cancer Facts & Figures 2007. Atlanta, GA: Society AC, 2007
3. Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-6.
4. Kaizu T, Karasawa K, Tanaka Y, et al. Radiotherapy for osseous metastases from hepatocellular carcinoma: a retrospective study of 57 patients. Am J Gastroenterol 1998; 93: 2167-71.
5. Patt YZ, Claghorn L, Charnsangavej C, et al. Hepatocellular carcinoma. A retrospective analysis of treatments to manage disease confined to the liver. Cancer 1988; 61: 1884-8.
6. Stuart KE, Anand AJ, Jenkins RL,. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 1996; 77: 2217-22.
7. Falkson G, MacIntyre JM, Moertel CG, et al. Primary liver cancer. An Eastern Cooperative Oncology Group Trial. Cancer 1984; 54: 970-7.
8. Doci R, Bignami P, Bozzetti F, et al. Intrahepatic chemotherapy for unresectable hepatocellular carcinoma. Cancer 1988; 61: 1983-7.
9. Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985; 56: 918-28.
10. Coleman WB,. Mechanisms of human hepatocarcinogenesis. Curr Mol Med 2003; 3: 573-88.
11. Arias AM,. Epithelial mesenchymal interactions in cancer and development. Cell 2001; 105: 425-31.
12. Thiery JP,. Epithelial-mesenchymal transitions in tumour progression. Nat Rev 2002; 2: 442-54.
13. Laffin B, Wellberg E, Kwak HI, et al. Loss of singleminded-2s in the mouse mammary gland induces an epithelial-mesenchymal transition associated with up-regulation of slug and matrix metalloprotease 2. Mol Cell Biol 2008; 28: 1936-46.
14. Huber MA, Kraut N, Beug H,. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005; 17: 548-58.
15. Matsuo N, Shiraha H, Fujikawa T, et al. Twist expression promotes migration and invasion in hepatocellular carcinoma. Cancer 2009; 9: 240: 1-12.
16. Frixen UH, Behrens J, Sachs M, et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991; 113: 173-85.
17. Umbas R, Schalken JA, Aalders TW, et al. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 1992; 52: 5104-9.
18. Cleton-Jansen AM, Moerland EW, Kuipers-Dijkshoorn NJ, et al. At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer. Genes Chromosomes Cancer 1994; 9: 101-7.
19. Carter BS, Ewing CM, Ward WS, et al. Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Nat Acad Sci USA 1990; 87: 8751-5.
20. Lee TK, Poon RT, Yuen AP, et al. Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res 2006; 12: 5369-76.
21. Jiao W, Miyazaki K, Kitajima Y,. Inverse correlation between E-cadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo. Br J Cancer 2002; 86: 98-101.
22. Thiery JP,. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003; 15: 740-6.
23. Boyer B, Valles AM, Edme N,. Induction and regulation of epithelial-mesenchymal transitions. Biochem Pharmacol 2000; 60: 1091-9.
24. Giannelli G, Bergamini C, Fransvea E, et al. Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma. Gastroenterol 2005; 129: 1375-83.
25. van Zijl F, Zulehner G, Petz M, et al. Epithelial-mesenchymal transition in hepatocellular carcinoma. Future Oncol 2009; 5: 1169-79.
26. Chen ZF, Behringer RR,. Twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev 1995; 9: 686-99.
27. Lee MS, Lowe GN, Strong DD, et al. TWIST, a basic helix-loop-helix transcription factor, can regulate the human osteogenic lineage. J Cell Biochem 1999; 75: 566-77.
28. Thisse B, el Messal M, Perrin-Schmitt F,. The twist gene: isolation of a Drosophila zygotic gene necessary for the establishment of dorsoventral pattern. Nucleic Acids Res 1987; 15: 3439-53.
29. Vernon AE, LaBonne C,. Tumor metastasis: a new twist on epithelial-mesenchymal transitions. Curr Biol 2004; 14: R719-21.
30. Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117: 927-39.
31. Li QL, Ito K, Sakakura C, et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002; 109: 113-24.
32. Araki K, Osaki M, Nagahama Y, et al. Expression of RUNX3 protein in human lung adenocarcinoma: implications for tumor progression and prognosis. Cancer Sci 2005; 96: 227-31.
33. Ku JL, Kang SB, Shin YK, et al. Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines. Oncogene 2004; 23: 6736-42.
34. Li J, Kleeff J, Guweidhi A, et al. RUNX3 expression in primary and metastatic pancreatic cancer. J Clin Pathol 2004; 57: 294-9.
35. Wada M, Yazumi S, Takaishi S, et al. Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines. Oncogene 2004; 23: 2401-07.
36. Li X, Zhang Y, Qiao T, et al. RUNX3 Inhibits growth of HCC cells and HCC xenografts in mice in combination with adriamycin. Cancer Biol Ther 2008; 7: 669-76.
37. Mori T, Nomoto S, Koshikawa K, et al. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma. Liver Int 2005; 25: 380-8.
38. Nakanishi Y, Shiraha H, Nishina SI, et al. Loss of runt-related transcription factor 3 expression leads hepatocellular carcinoma cells to escape apoptosis. BMC Cancer 2011; 11: 3: 1-10.
39. Xiao WH, Liu WW,. Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma. World J Gastroenterol 2004; 10: 376-80.
40. Nishina S, Shiraha H, Nakanishi Y, et al. Restored expression of the tumor suppressor gene RUNX3 reduces cancer stem cells in hepatocellular carcinoma by suppressing Jagged1-Notch signaling. Oncol Rep 2011; 26: 523-31.
41. Weijzen S, Velders MP, Elmishad AG, et al. The Notch ligand Jagged-1 is able to induce maturation of monocyte-derived human dendritic cells. J Immunol 2002; 169: 4273-8.
42. Ng IO, Chung LP, Tsang SW, et al. p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese. Oncogene 1994; 9: 985-90.
43. Savagner P, Yamada KM, Thiery JP,. The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J Cell Biol 1997; 137: 1403-19.
44. Yoshiura K, Kanai Y, Ochiai A, et al. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Nat Acad Sci USA 1995; 92: 7416-9.
45. Kanai Y, Ushijima S, Hui AM, et al. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int J Cancer 1997; 71: 355-9.
46. Matsumura T, Makino R, Mitamura K,. Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas. Clin Cancer Res 2001; 7: 594-9.
47. Aleksic K, Lackner C, Geigl JB, et al. Evolution of genomic instability in diethylnitrosamine-induced hepatocarcinogenesis in mice. Hepatol 2011; 53: 895-904.
48. Arima Y, Inoue Y, Shibata T, et al. Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition. Cancer Res 2008; 68: 5104-12.
49. Chang TL, Ito K, Ko TK, et al. Claudin-1 has tumor suppressive activity and is a direct target of RUNX3 in gastric epithelial cells. Gastroenterol 2010; 138: 255-65 e1-3.
50. Shiraha H, Nishina SI, Yamamoto K,. Loss of runt-related transcription factor 3 causes development and progression of hepatocellular carcinoma. J Cell Biochem 2011; 112: 745-49.